Michael Stitzel, Ph.D.

Associate Professor

(De)coding the regulatory landscape of human pancreatic islets and other metabolic cell types health and diabetes

Type 2 diabetes is a disease of genes and environment. My laboratory studies the epigenome of human pancreatic islets and their developmental precursor cells. One aim is to use the epigenome as a read-out of effects of type 2 diabetes genetic variants on islet gene expression programs and function. Emerging evidence suggests that normal or disease-predisposing conditions can actually alter a cell's epigenome and lead to abnormal cellular functions. To this end, my lab is investigating how the islet epigenome is altered under different stimulatory and stress conditions. Finally, we are pursuing targeted modification of cells’ epigenomes to facilitate production of bona fide pancreatic islet cells from pluripotent stem cells or other terminally differentiated cells.

                      Download cv                      

            Michael Stitzel on ORCID           

EndoC-βH1 and Human Islet Genomics

Education and experience


Associate Professor (2019-present)
Assistant Professor (2013-2019)
Adjunct Faculty, Department of Genetics and Genome Sciences, UConn (2013-present)
Member, Institute of Systems Genomics, UConn (2015-present)

Grants, awards and accomplishments

2014 - American Diabetes Association Young Investigator Travel Grant Award

2013 - Genome Technology Young Investigators of the Year Award

2012 - Endocrine Society Early Investigator’s Workshop for Trainees

2011 - NIH Fellows Award for Research Excellence

2005 - Best Graduate Presentation, Johns Hopkins McKusick-Nathans Institute of Genetic Medicine Retreat

2002, 2003 - Honorable Mention, NSF Graduate Research Fellowship

2000 - William J. Fulbright Scholarship

2000 - National Institutes of Health Summer Research Fellowship